|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 94 No. 8 (October 15), 1999:
pp. 2890-2894
The Molecular Basis of a Case of  -Glutamylcysteine Synthetase
Deficiency
Ernest Beutler,
Terri Gelbart,
Takahito Kondo, and
Alison T. Matsunaga
From the Department of Molecular and Experimental Medicine, The
Scripps Research Institute, La Jolla, CA; the Department of
Biochemistry and Molecular Biology in Disease, Atomic Bomb Disease
Institute, Nagasaki University School of Medicine, Nagasaki, Japan; and
the Children's Hospital Medical Center, Oakland, CA.
 -Glutamylcysteine synthetase catalyzes the first step in
glutathione synthesis. The enzyme consists of 2 subunits, heavy and
light, with the heavy subunit serving as the catalytic subunit. A
patient with hemolytic anemia and low red blood cell glutathione levels
was found to have a deficiency of -glutamylcysteine synthetase activity. Examination of cDNA from the patient and her mother showed
that she was homozygous and that her mother was heterozygous for a
A T transversion at nt1109 producing a deduced amino acid change of His370Leu. The partial genomic structure of the catalytic subunit of -glutamylcysteine synthetase (GLCLC) was
determined, providing some intron/exon boundaries to make it possible
to sequence an affected part of the coding region from genomic DNA. The
1109AT mutation was not present in the DNA of 38 normal
subjects. In the course of these studies we found a diallelic
polymorphism in nt +206 of an intron and another polymorphism that
consisted of a duplication of a CAGC at cDNA nt1972-1975 in the
3' untranslated region. The 2 polymorphisms were found to be only
in partial linkage disequilibrium.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
M. Manu Pereira, T. Gelbart, E. Ristoff, K.C. Crain, J.M. Bergua, A. Lopez Lafuente, S.G. Kalko, E. Garcia Mateos, E. Beutler, and J.L. Vives Corrons
Chronic non-spherocytic hemolytic anemia associated with severe neurological disease due to {gamma}-glutamylcysteine synthetase deficiency in a patient of Moroccan origin
Haematologica,
November 1, 2007;
92(11):
e102 - e105.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Gysin, R. Kraftsik, J. Sandell, P. Bovet, C. Chappuis, P. Conus, P. Deppen, M. Preisig, V. Ruiz, P. Steullet, et al.
Impaired glutathione synthesis in schizophrenia: Convergent genetic and functional evidence
PNAS,
October 16, 2007;
104(42):
16621 - 16626.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Shah, M. Budev, H. Blazey, K. Fairbanks, and A. Mehta
Hepatic veno-occlusive disease due to tacrolimus in a single-lung transplant patient.
Eur. Respir. J.,
May 1, 2006;
27(5):
1066 - 1068.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M.-S. S. Alhamdani
Impairment of glutathione biosynthetic pathway in uraemia and dialysis
Nephrol. Dial. Transplant.,
January 1, 2005;
20(1):
124 - 128.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G J Breedveld, B van Wetten, G D te Raa, E Brusse, J C van Swieten, B A Oostra, and J A Maat-Kievit
A new locus for a childhood onset, slowly progressive autosomal recessive spinocerebellar ataxia maps to chromosome 11p15
J. Med. Genet.,
November 1, 2004;
41(11):
858 - 866.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Hibi, H. Nii, T. Nakatsu, A. Kimura, H. Kato, J. Hiratake, and J. Oda
Crystal structure of {gamma}-glutamylcysteine synthetase: Insights into the mechanism of catalysis by a key enzyme for glutathione homeostasis
PNAS,
October 19, 2004;
101(42):
15052 - 15057.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Hamilton, J. H. Wu, M. Alaoui-Jamali, and G. Batist
A novel missense mutation in the {gamma}-glutamylcysteine synthetase catalytic subunit gene causes both decreased enzymatic activity and glutathione production
Blood,
July 15, 2003;
102(2):
725 - 730.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-i. Koide, K. Kugiyama, S. Sugiyama, S.-i. Nakamura, H. Fukushima, O. Honda, M. Yoshimura, and H. Ogawa
Association of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarction
J. Am. Coll. Cardiol.,
February 19, 2003;
41(4):
539 - 545.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-i. Nakamura, K. Kugiyama, S. Sugiyama, S. Miyamoto, S.-i. Koide, H. Fukushima, O. Honda, M. Yoshimura, and H. Ogawa
Polymorphism in the 5'-Flanking Region of Human Glutamate-Cysteine Ligase Modifier Subunit Gene Is Associated With Myocardial Infarction
Circulation,
June 25, 2002;
105(25):
2968 - 2973.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. C. Walsh, J. A. Feulner, and A. Reilly
Evidence for Functionally Significant Polymorphism of Human Glutamate Cysteine Ligase Catalytic Subunit: Association with Glutathione Levels and Drug Resistance in the National Cancer Institute Tumor Cell Line Panel
Toxicol. Sci.,
June 1, 2001;
61(2):
218 - 223.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Ristoff, C. Augustson, J. Geissler, T. de Rijk, K. Carlsson, J.-L. Luo, K. Andersson, R. S. Weening, R. van Zwieten, A. Larsson, et al.
A missense mutation in the heavy subunit of gamma -glutamylcysteine synthetase gene causes hemolytic anemia
Blood,
April 1, 2000;
95(7):
2193 - 2196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
